Facioscapulohumeral Muscular Dystrophy and Accompanying Hearing Loss

1984 ◽  
Vol 110 (4) ◽  
pp. 261-266 ◽  
Author(s):  
M. D. Meyerson ◽  
E. Lewis ◽  
Karen
Neurology ◽  
2018 ◽  
Vol 92 (4) ◽  
pp. e378-e385 ◽  
Author(s):  
Rianne J.M. Goselink ◽  
Karlien Mul ◽  
Caroline R. van Kernebeek ◽  
Richard J.L.F. Lemmers ◽  
Silvère M. van der Maarel ◽  
...  

ObjectiveTo assess the relation between age at onset and disease severity in facioscapulohumeral muscular dystrophy (FSHD).MethodsIn this prospective cross-sectional study, we matched adult patients with FSHD with an early disease onset with 2 sex-matched FSHD control groups with a classic onset; the first group was age matched, and the second group was disease duration matched. Genetic characteristics, muscle performance, respiratory functioning, hearing loss, vision loss, epilepsy, educational level, and work status were compared with the 2 control groups.ResultsTwenty-eight patients with early-onset FSHD were age (n = 28) or duration (n = 27) matched with classic-onset patients. Patients with early-onset FSHD had more severe muscle weakness (mean FSHD clinical score 11 vs 5 in the age-matched and 9 in the duration-matched group, p < 0.05) and a higher frequency of wheelchair dependency (57%, 0%, and 30%, respectively, p < 0.05). In addition, systemic features were more frequent in early-onset FSHD, most important, hearing loss, decreased respiratory function and spinal deformities. There was no difference in work status. Genetically, the shortest D4Z4 repeat arrays (2–3 units) were found exclusively in the early-onset group, and the largest repeat arrays (8–9 units) were found only in the classic-onset groups. De novo mutations were more frequent in early-onset patients (46% vs 4%).ConclusionsPatients with early-onset FSHD more often have severe muscle weakness and systemic features. The disease severity is greater than in patients with classic-onset FSHD who are matched for disease duration, suggesting that the progression is faster in early-onset patients.


Neurology ◽  
2013 ◽  
Vol 81 (16) ◽  
pp. 1374-1377 ◽  
Author(s):  
K. L. Lutz ◽  
L. Holte ◽  
S. A. Kliethermes ◽  
C. Stephan ◽  
K. D. Mathews

1995 ◽  
Vol 18 (S13) ◽  
pp. S73-S80 ◽  
Author(s):  
G. W. Padberg ◽  
O. F. Brouwer ◽  
R. J. W. de Keizer ◽  
G. Dijkman ◽  
C. Wijmenga ◽  
...  

Neurology ◽  
1991 ◽  
Vol 41 (12) ◽  
pp. 1878-1878 ◽  
Author(s):  
O. F. Brouwer ◽  
G. W. Padberg ◽  
C.J.M. Ruys ◽  
R. Brand ◽  
J. A.P.M. de ◽  
...  

2006 ◽  
Vol 21 (3) ◽  
pp. 252-253
Author(s):  
Lisa D. Hobson-Webb

Facioscapulohumeral muscular dystrophy is one of the most prevalent muscular dystrophies in the world, resulting from the deletion of tandem repeats on chromosome 4q35. Extramuscular associations include sensorineural hearing loss, mental retardation, and epilepsy. These manifestations are commonly found in those with large deletions and early onset of weakness. A 26-year-old patient with a long-standing history of hearing loss, learning disabilities, and epilepsy presented with new-onset weakness and an elevated serum creatinine kinase level. Genetic testing confirmed sporadic facioscapulohumeral muscular dystrophy with a fragment length of 12 kilobases (normal > 35 kilobases). This unique presentation suggests that facioscapulohumeral muscular dystrophy should be considered in the differential diagnosis of children with cognitive impairment, seizures, and hearing loss. ( J Child Neurol 2006;21:252—253; DOI 10.2310/7010.2006.00054).


2008 ◽  
Vol 15 (12) ◽  
pp. 1353-1358 ◽  
Author(s):  
C. P. Trevisan ◽  
E. Pastorello ◽  
G. Tomelleri ◽  
L. Vercelli ◽  
C. Bruno ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document